SGLT2 Inhibitors Across the EF Spectrum

In this episode, Clyde W. Yancy, MD, MSc, MACC, and Leslie L. Davis, NP, PhD, FACC, discuss the 2023 ACC Expert Consensus Decision Pathway on Management of Patients with HFpEF, and where to consider newer treatments with guideline-directed medical therapy.

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast